295 related articles for article (PubMed ID: 20615818)
1. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
Brunasso AM; Massone C
Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
[No Abstract] [Full Text] [Related]
2. Moderate to severe hidradenitis suppurativa treated with biological therapies.
Chinniah N; Cains GD
Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
[TBL] [Abstract][Full Text] [Related]
3. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
4. Etanercept for the treatment of hidradenitis suppurativa.
Sotiriou E; Apalla Z; Ioannidos D
Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
[No Abstract] [Full Text] [Related]
5. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
6. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature.
Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB
Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035
[TBL] [Abstract][Full Text] [Related]
7. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.
Lozeron P; Denier C; Lacroix C; Adams D
Arch Neurol; 2009 Apr; 66(4):490-7. PubMed ID: 19364934
[TBL] [Abstract][Full Text] [Related]
8. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950
[No Abstract] [Full Text] [Related]
9. Long-term efficacy of etanercept in hidradenitis suppurativa.
Zangrilli A; Esposito M; Mio G; Mazzotta A; Chimenti S
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1260-2. PubMed ID: 18331322
[No Abstract] [Full Text] [Related]
10. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?
Brunasso AM; Delfino C; Massone C
Br J Dermatol; 2008 Sep; 159(3):761-3. PubMed ID: 18627370
[No Abstract] [Full Text] [Related]
11. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
Harde V; Mrowietz U
J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
[TBL] [Abstract][Full Text] [Related]
12. Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
Alsharqi A; Parslew R; Dever B; Arslanian V
Australas J Dermatol; 2012 May; 53(2):e45-7. PubMed ID: 22571585
[No Abstract] [Full Text] [Related]
13. [1/2 The anti-TNF alpha drugs].
Medjoub M; Limat S; Woronoff-Lemsi MC
Soins; 2007 Oct; (719):59-61. PubMed ID: 18020248
[No Abstract] [Full Text] [Related]
14. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
[No Abstract] [Full Text] [Related]
15. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
Koilakou S; Karapiperis D; Tzathas C
Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
[No Abstract] [Full Text] [Related]
16. Advertisements for TNF Inhibitors.
Med Lett Drugs Ther; 2008 Nov; 50(1299):89. PubMed ID: 19008788
[No Abstract] [Full Text] [Related]
17. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
Haslund P; Lee RA; Jemec GB
Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
[TBL] [Abstract][Full Text] [Related]
18. Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa.
Savva A; Kanni T; Damoraki G; Kotsaki A; Giatrakou S; Grech I; Katoulis A; Papadavid E; Giamarellos-Bourboulis EJ
Br J Dermatol; 2013 Feb; 168(2):311-7. PubMed ID: 23106544
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
Brunasso AM; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
[No Abstract] [Full Text] [Related]
20. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
Shuja F; Chan CS; Rosen T
Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
